Methylenetetrahydrofolate reductase polymorphism in advanced colorectal cancer: a novel genomic predictor of clinical response to fluoropyrimidine-based chemotherapy by Cohen Victor, Panet-Raymond Valerie, Sabbaghian Nelly, Morin Isabelle, Batist Gerald, Rozen Rima in Clinical cancer research : an official journal of the American Association for Cancer Research (2003).

[PMID: 12738713] PubMed


Discussed In Paper


Rx Annotations

No dosing information annotated.